Join
Live feed
·
INSIDERFilingvia Quantisnow
G1 Therapeutics Inc. logo

President and CEO Bailey John E. (Jack) Jr. was granted 181,400 shares and returned 534,787 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GTHX· G1 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GTHX (G1 Therapeutics Inc.) and more on Quantisnow.